Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 1.717% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CN(C(=O)COc1ccc(Cl)cc1Br)C1CCCCC1
b.) CCOc1ccc(-c2cc(N)n(S(=O)(=O)c3cccc4nsnc34)n2)cc1
c.) CCOc1ccccc1C(=O)Nc1cc(C(=O)NCCc2ccccc2)ccc1Cl
d.) Cn1nc([N+](=O)[O-])c2c(-c3nc4ccccc4s3)c(N)n(C3CCCCC3)c2c1=O
e.) Cc1c(C(=O)NCc2ccc3c(c2)OCO3)oc2ccc(Br)cc12
Answer: e. Cc1c(C(=O)NCc2ccc3c(c2)OCO3)oc2ccc(Br)cc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(C(=O)NCc2ccc3c(c2)OCO3)oc2ccc(Br)cc12
Cc1c(C(=O)NCc2ccc3c(c2)OCO3)oc2ccc(Br)cc12
N-(1,3-benzodioxol-5-ylmethyl)-5-bromo-3-methyl-1-benzofuran-2-carboxamide